BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Credit Suisse maintains neutral on Torrent Pharma
Company's filing rate to step up from FY17. Company is targeting $500 million turnover by 2020. Elder Pharma integration running a year ahead of targets. Brazil currency impact partially offset by cost initiatives. Credit Suisse increases FY16/17 earnings per share estimates by 12 and 7 per cent respectively.